ME
ZY

McIlrath & Eck’s Zymergen Inc. Common Stock ZY Stock Holding History

McIlrath & Eck’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50
Closed – – 931
2022
Q3 		$0 Hold
50
– – ﹤0.01% 917
2022
Q2 		$0 Hold
50
– – ﹤0.01% 894
2022
Q1 		$0 Hold
50
– – ﹤0.01% 855
2021
Q4 		$0 Hold
50
– – ﹤0.01% 857
2021
Q3 		$1K Hold
50
– – ﹤0.01% 792
2021
Q2 		$2K Buy
+50
New +$1.97K ﹤0.01% 729

McIlrath & Eck's ZY Position: Q4 2022 in Review

McIlrath & Eck sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 50 shares.

McIlrath & Eck first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $2K in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • McIlrath & Eck reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • McIlrath & Eck sold 50 Zymergen Inc. Common Stock shares in Q4 2022.
  • McIlrath & Eck first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • McIlrath & Eck's Zymergen Inc. Common Stock position peaked at $2K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on McIlrath & Eck's 13F filing for Q4 2022, filed 15 Feb 2023.